본문 바로가기
KERD
논문KCI 등재

Status and Trends of the Digital Healthcare Industry

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Objectives: This review presents a comprehensive overview of the rapidly evolving digital healthcare industry, aiming to provide a broad understanding of the recent landscape and directions for the future of digital healthcare. Methods: This review examines the key trends in sectors of the digital healthcare industry, which can be divided into four main categories: digital hardware, software solutions, platforms, and enablers. We discuss electroceuticals, wearables, standalone medical software, non-medical health management services, telehealth, decentralized clinical trials, and infrastructural systems such as health data systems. The review covers both global and domestic perspectives, addressing definitions, significance, revenue trends, major companies, regulations, and socioenvironmental factors. Results: Diverse growth patterns are evident across digital healthcare sectors. The applications of electroceuticals are expanding. Wearables are becoming more ubiquitous, facilitating continuous health monitoring and data collection. Artificial intelligence in standalone medical software is demonstrating clinical efficacy, with regulatory frameworks adapting to support commercialization. Non-medical health management services are expanding their scope to address chronic conditions under professional guidance. Telemedicine and decentralized clinical trials are gaining traction, driven by the need for flexible healthcare solutions post-pandemic. Efforts to build robust digital infrastructure with health data are underway, supported by data banks and data aggregation platforms. Conclusions: Advancements in digital healthcare create a dynamic, transformative landscape, integrating, complementing, and offering alternatives to traditional paradigms. This evolution is driven by continuous innovation, increased stakeholder participation, regulatory adaptations promoting commercialization, and supportive initiatives. Ongoing discussions about optimal digital technology integration and effective healthcare strategy implementation are essential for progress.

Abstract

Objectives: This review presents a comprehensive overview of the rapidly evolving digital healthcare industry, aiming to provide a broad understanding of the recent landscape and directions for the future of digital healthcare. Methods: This review examines the key trends in sectors of the digital healthcare industry, which can be divided into four main categories: digital hardware, software solutions, platforms, and enablers. We discuss electroceuticals, wearables, standalone medical software, non-medical health management services, telehealth, decentralized clinical trials, and infrastructural systems such as health data systems. The review covers both global and domestic perspectives, addressing definitions, significance, revenue trends, major companies, regulations, and socioenvironmental factors. Results: Diverse growth patterns are evident across digital healthcare sectors. The applications of electroceuticals are expanding. Wearables are becoming more ubiquitous, facilitating continuous health monitoring and data collection. Artificial intelligence in standalone medical software is demonstrating clinical efficacy, with regulatory frameworks adapting to support commercialization. Non-medical health management services are expanding their scope to address chronic conditions under professional guidance. Telemedicine and decentralized clinical trials are gaining traction, driven by the need for flexible healthcare solutions post-pandemic. Efforts to build robust digital infrastructure with health data are underway, supported by data banks and data aggregation platforms. Conclusions: Advancements in digital healthcare create a dynamic, transformative landscape, integrating, complementing, and offering alternatives to traditional paradigms. This evolution is driven by continuous innovation, increased stakeholder participation, regulatory adaptations promoting commercialization, and supportive initiatives. Ongoing discussions about optimal digital technology integration and effective healthcare strategy implementation are essential for progress.

참고문헌 (74)

  1. "Digital Health Euro" (2022)[URL]
  2. Abernethy A, "The promise of digital health : then, now, and the future", NAM Perspect, 2022, pp.1~24 (2022)[DOI]
  3. Vial G, "Understanding digital transformation : a review and a research agenda", J Strateg Inf Syst, 28(2), pp.118~144 (2019)[DOI]
  4. Survey on the current status of the digital healthcare industry and measures for activation, "Korea Digital Health Industry Association", Digital Health Industry Association, ~ (2022)
  5. "The advancement of digital healthcare:current status of telemedicine" (2022)[URL]
  6. "ICT global market analysis: market trends by ICT product categories:digital healthcare 2023" (2023)[URL]
  7. "Digital health market" (2023)[URL]
  8. "Report on the digital healthcare industry survey" (2024)[URL]
  9. "Digital health - South Korea" (2024)[URL]
  10. "Real economic growth rates of major countries in 2020" (2021)[URL]
  11. "Analysis of economic conditions in major countries in 2021 (NABO Briefing, Vol. 117)" (2021)[URL]
  12. "World Bank Reports “Entering Worst Low-Growth Track in 30 Years” with Release of ‘World Economic Outlook’" (2024)[URL]
  13. "Global Health Industry Trends, Vol. 505" (2024)[URL]
  14. "In-depth study of global health industry trends for the first half of 2024" (2024)[URL]
  15. Bitkina OV, "Application of artificial intelligence in medical technologies : a systematic review of main trends", Digit Health, 9, pp.20552076231189331~ (2023)[DOI]
  16. "Global expansion strategy of digital healthcare companies: focusing on SW medical devices" (2023)[URL]
  17. "ASTI Market Insight 65: AI in medicine and healthcare" (2022)[URL]
  18. Yu P, "Leveraging generative AI and large language models : a comprehensive roadmap for healthcare integration", Healthcare(Basel), 11(20), pp.2776~ (2023)[DOI]
  19. Clusmann J, "The future landscape of large language models in medicine", Commun Med(Lond), 3(1), pp.141~ (2023)[DOI]
  20. "Global Health Industry Trends, Vol. 506" (2024)[URL]
  21. "ICT trends by GIP product category: healthcare 2024" (2024)[URL]
  22. "Global Health Industry Trends, Vol. 507" (2024)[URL]
  23. "Policies for activating the digital healthcare industry: traces and new leaps" (2021)[URL]
  24. "Health Industry Brief, Vol. 399" (2024)[URL]
  25. "Digital therapeutics and electronic prescriptions:what’s the difference?" (2023)[URL]
  26. Magisetty R, "New era of electroceuticals : clinically driven smart implantable electronic devices moving towards precision therapy", Micromachines(Basel), 13(2), pp.161~ (2022)[DOI]
  27. "Optune Gio" (2024)[URL]
  28. "World’s first release of ‘Depression Electronic Pill’... “More Benefits than Medication”" (2023)[URL]
  29. "YBrain’s MindSteam, the electronic pill for depression, adopted by over 100 hospitals" (2023)[URL]
  30. Deng Z, "Smart wearable systems for health monitoring", Sensors(Basel), 23(5), pp.2479~ (2023)[DOI]
  31. "ICT global market analysis: market trends by ICT product categories:digital healthcare 2022" (2022)[URL]
  32. "Diabetes care" (2024)[URL]
  33. "Diagnostic AI" (2024)[URL]
  34. "From healthcare smart rings to medical robots... Samsung’s ‘Expansion Instinct for Medical Devices’" (2024)[URL]
  35. "When administering anticancer drugs, does money accumulate? Reasons for anticipation of Lunit’s ‘SCOPE’" (2023)[URL]
  36. "Lunit" (2021)[URL]
  37. "Lunit continues its overseas IR activities... ‘Visualizing Global Achievements’" (2023)[URL]
  38. "Digital Therapeutics Alliance" (2023)[URL]
  39. "Digital therapeutics and SaMD" (2021)[URL]
  40. "Current status and outlook of the domestic and international digital therapeutics (DTx) Industry" (2023)[URL]
  41. "Guidelines for Approval and Review of Digital Therapeutic Devices" (2020)[URL]
  42. "Health Industry Brief, Vol. 371: Major Countries’ policies and industry trends related to DTx" (2023)[URL]
  43. "Bio Economy Brief 140: Trends in the global healthcare service market and key technological and institutional issues" (2022)[URL]
  44. "Regulation cases and issues in response to technological innovation II: compensation for digital innovative medical technology" (2023)[URL]
  45. "Comprehensive overview: FDA’s DTx Approvals in 2023" (2024)[URL]
  46. Phan P, "Digital therapeutics in the clinic", Bioeng Transl Med, 8(4), pp.e10536~ (2023)
  47. "Press Release: Seminar on integrated review and evaluation system for innovative medical devices" (2022)[URL]
  48. "Evaluation Guidelines for the Coverage of Innovative Medical Technologies: Artificial Intelligence-based Innovative Medical Technologies" (2023)[URL]
  49. "Guidelines for Health Insurance Inclusion of Digital Therapeutic Devices" (2023)[URL]
  50. "Concrete steps towards health insurance coverage for innovative medical devices... industry breathes a sigh of relief" (2023)[URL]
  51. "Food and Drug Administration Grants Approval for ‘Digital Therapeutic Devices’ Numbers 3 and 4" (2024)[URL]
  52. "Guidelines and casebook for non-medical health management services (1st edition)" (2019)[URL]
  53. "Guidelines and casebook for non-medical health management services (2nd edition)" (2022)[URL]
  54. "‘Non-medical health management services’spread wings... ‘Principle of impossibility → Limited permission’" (2022)[URL]
  55. "12 types of ‘non-medical health management services’ obtain pilot certification... Plan for ‘full-scale linkage’ of 1st-tier services" (2022)[URL]
  56. "The evolving customized US Telehealth Market:what opportunities await our companies?" (2024)[URL]
  57. "Global ICT Issue Report: post-COVID-19growth of major countries’ remote medical platforms" (2021)[URL]
  58. "Health Industry Brief Vol. 405" (2024)[URL]
  59. "“I must survive”... The era of non-face-to-face medical platforms" (2023)[URL]
  60. "Healthcare Informatics Research Institute Report No. 572: remote medical policy directions in major countries post-pandemic" (2023)[URL]
  61. "Decentralized clinical trials: no longer an option but a necessity" (2023)[URL]
  62. "Special Report: Rapid steps in decentralized clinical trials worldwide... Korea, can’t even lift a foot" (2023)[URL]
  63. "Untangling the ‘regulations’ blocking the introduction of domestic DCT... how to resolve the entwined issues" (2023)[URL]
  64. "Health Industry Brief Vol. 388: The impact of introducing medical MyData on the economic aspects of the healthcare data industry" (2023)[URL]
  65. "Health Industry Brief Vol. 389: Analysis of relevant trends and implications for effective integration of bio big data and healthcare data platforms" (2023)[URL]
  66. "Health Industry Brief Vol. 395" (2023)[URL]
  67. "Press Release: Preliminary Feasibility Study Passed for ‘1 Million People Bio Big Data Construction Project’" (2023)[URL]
  68. "Health Industry Brief Vol. 368: Survey of overseas cases for the introduction of MyData in the domestic medical field" (2022)[URL]
  69. Ha T, "Status of MyHealthWay and suggestions for widespread implementation, emphasizing the utilization and practical use of personal medical data", Healthc Inform Res, 30(2), pp.103~112 (2024)[DOI]
  70. "Simultaneous access to 12 types of personal health information... ‘Health Information Highway’ officially launched" (2023)[URL]
  71. "Personal Information Protection Act" (2024)[URL]
  72. "Risks and development directions of personal information transfer rights and MyData" (2023)[URL]
  73. "Digital Healthcare and Law: collection, utilization, and restrictions of medical data" (2022)[URL]

관련 논문AI추천

이 간행물의 다른 논문 (12건)